Identification of a region within the ErbB2/HER2 intracellular domain that is necessary for ligand-independent association
- PMID: 12000754
- DOI: 10.1074/jbc.M202510200
Identification of a region within the ErbB2/HER2 intracellular domain that is necessary for ligand-independent association
Abstract
Ligand-independent ErbB2 activation occurs principally by two distinct mechanisms: overexpression and mutation. Overexpression of ErbB2 at the plasma membrane drives receptor self-association in a concentration-dependent manner, which in turn leads to constitutive receptor activation. Subsets of human breast cancers contain a molecular alteration that leads to erbB2 gene amplification and subsequent protein overexpression. Although not recognized to occur in human cancers, mutation can also lead to increased ErbB2 association. A well characterized mutant of the rodent ortholog neu involves substitution of glutamate for valine within the transmembrane domain. In each case, a number of explanations have been proposed to explain the resulting ErbB2 activation. These include stabilization of receptor oligomers, release of negative constraints, and altered receptor conformations. Here we define a short amino acid segment comprising amino acids 966-968 in the intracellular domain that seemingly disrupts receptor-receptor association that is driven either by overexpression or mutation in the transmembrane region. Because of the hydrophobic nature of these amino acids (VVI), we propose that alteration of this segment likely results in a global conformational change in an area that has been proposed previously to be a dimerization motif for ErbB homomeric association.
Similar articles
-
The single transmembrane domains of ErbB receptors self-associate in cell membranes.J Biol Chem. 2002 Feb 15;277(7):4704-12. doi: 10.1074/jbc.M108681200. Epub 2001 Dec 10. J Biol Chem. 2002. PMID: 11741943
-
A putative molecular-activation switch in the transmembrane domain of erbB2.Proc Natl Acad Sci U S A. 2002 Dec 10;99(25):15937-40. doi: 10.1073/pnas.252640799. Epub 2002 Dec 2. Proc Natl Acad Sci U S A. 2002. PMID: 12461170 Free PMC article.
-
Sequence-dependent oligomerization of the Neu transmembrane domain suggests inhibition of "conformational switching" by an oncogenic mutant.Biochemistry. 2010 Apr 6;49(13):2811-20. doi: 10.1021/bi902087v. Biochemistry. 2010. PMID: 20180588
-
The ErbB/HER receptor protein-tyrosine kinases and cancer.Biochem Biophys Res Commun. 2004 Jun 18;319(1):1-11. doi: 10.1016/j.bbrc.2004.04.150. Biochem Biophys Res Commun. 2004. PMID: 15158434 Review.
-
Structural requirements for ErbB2 transactivation.Semin Oncol. 2001 Dec;28(6 Suppl 18):36-42. Semin Oncol. 2001. PMID: 11774204 Review.
Cited by
-
ErbB2 dephosphorylation and anti-proliferative effects of neuregulin-1 in ErbB2-overexpressing cells; re-evaluation of their low-affinity interaction.Sci Rep. 2013;3:1402. doi: 10.1038/srep01402. Sci Rep. 2013. PMID: 23466678 Free PMC article.
-
Ebselen oxide and derivatives are new allosteric HER2 inhibitors for HER2-positive cancers.Mol Oncol. 2023 Oct;17(10):1981-1999. doi: 10.1002/1878-0261.13419. Epub 2023 Mar 27. Mol Oncol. 2023. PMID: 36912768 Free PMC article.
-
Signal integration: a framework for understanding the efficacy of therapeutics targeting the human EGFR family.J Clin Invest. 2008 Nov;118(11):3574-81. doi: 10.1172/JCI36049. J Clin Invest. 2008. PMID: 18982164 Free PMC article. Review.
-
Distribution of resting and ligand-bound ErbB1 and ErbB2 receptor tyrosine kinases in living cells using number and brightness analysis.Proc Natl Acad Sci U S A. 2010 Sep 21;107(38):16524-9. doi: 10.1073/pnas.1002642107. Epub 2010 Sep 2. Proc Natl Acad Sci U S A. 2010. PMID: 20813958 Free PMC article.
-
Preexisting oncogenic events impact trastuzumab sensitivity in ERBB2-amplified gastroesophageal adenocarcinoma.J Clin Invest. 2014 Dec;124(12):5145-58. doi: 10.1172/JCI75200. Epub 2014 Nov 17. J Clin Invest. 2014. PMID: 25401468 Free PMC article. Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous